Results 1 to 10 of about 2,529,459 (356)
Protocol for assessing T cell receptor-mediated human T cell cytotoxicity [PDF]
Summary: Measuring the cytotoxicity of human T cells is a valuable but challenging task. We present a protocol for assessing the ability of polyclonal human T cells to kill target cells upon T cell receptor (TCR) triggering.
Kathryne E. Marks+3 more
doaj +2 more sources
TRain: T-cell receptor automated immunoinformatics [PDF]
Background The scarcity of available structural data makes characterizing the binding of T-cell receptors (TCRs) to peptide-Major Histocompatibility Complexes (pMHCs) very challenging.
Austin Seamann+5 more
doaj +2 more sources
The T cell receptor sequence influences the likelihood of T cell memory formation [PDF]
Summary: The amino acid sequence of the T cell receptor (TCR) varies between T cells of an individual’s immune system. Particular TCR residues nearly guarantee mucosal-associated invariant T (MAIT) and natural killer T (NKT) cell transcriptional fates ...
Kaitlyn A. Lagattuta+7 more
doaj +2 more sources
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen [PDF]
T cell receptor-engineered T cells (TCR-T) could be advantageous in glioblastoma by allowing safe and ubiquitous targeting of the glioblastoma-derived peptidome.
Yu-Chan Chih+28 more
doaj +2 more sources
T-cell receptor and B-cell receptor repertoires profiling in pleural tuberculosis [PDF]
BackgroundTuberculosis (TB) is a leading cause of death worldwide from a single infectious agent. In China the most common extra-pulmonary TB (EPTB) is pleural tuberculosis (PLTB).
Fengjiao Du+12 more
doaj +2 more sources
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
Healthy T cells are polyclonal, while malignant T cells are developing via clonal expansion. Here authors show that T cell tumours could be eradicated by chimeric antigen receptor T cells targeting the T cell receptor (TCR) β-chain that is specific to ...
Fanlin Li+17 more
doaj +1 more source
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Transcription factor and oncosuppressor protein p53 is considered as one of the most promising molecular targets that remains a high-hanging fruit in cancer therapy.
Vitaly Chasov+9 more
doaj +1 more source
The inhibition of anabolic pathways, such as aerobic glycolysis, is a metabolic cornerstone of memory T cell differentiation and function. However, the signals that hamper these anabolic pathways are not completely known.
Raquel Blanco+8 more
doaj +1 more source
Background T cell clonality assays in veterinary medicine currently target only the T cell receptor gamma (TRG) locus. Existing assays have suboptimal sensitivity because of insufficient primer coverage of all possible rearrangements.
Araya Radtanakatikanon+3 more
doaj +1 more source
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
Antigen-specific retargeting of cytotoxic lymphocytes against tumorassociated antigens has thus far remained largely dependent on chimeric antigen receptors (CARs) that can be constructed by the fusion of an extracellular targeting domain (classically a ...
Zeynep Sena Karahan+2 more
doaj +1 more source